Your browser doesn't support javascript.
loading
The History of Chromosomal Instability in Genome-Doubled Tumors.
Baker, Toby M; Lai, Siqi; Lynch, Andrew R; Lesluyes, Tom; Yan, Haixi; Ogilvie, Huw A; Verfaillie, Annelien; Dentro, Stefan; Bowes, Amy L; Pillay, Nischalan; Flanagan, Adrienne M; Swanton, Charles; Spellman, Paul T; Tarabichi, Maxime; Van Loo, Peter.
Afiliación
  • Baker TM; The Francis Crick Institute, London, United Kingdom.
  • Lai S; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lynch AR; Department of Medicine, University of California Los Angeles, Los Angeles, California.
  • Lesluyes T; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Yan H; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ogilvie HA; The Francis Crick Institute, London, United Kingdom.
  • Verfaillie A; The Francis Crick Institute, London, United Kingdom.
  • Dentro S; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bowes AL; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Pillay N; The Francis Crick Institute, London, United Kingdom.
  • Flanagan AM; Division of AI in Oncology, German Cancer Research Centre DKFZ, Heidelberg, Germany.
  • Swanton C; The Francis Crick Institute, London, United Kingdom.
  • Spellman PT; Research Department of Pathology, Cancer Institute, University College London, London, United Kingdom.
  • Tarabichi M; Department of Cellular and Molecular Pathology, Royal National Orthopaedic Hospital NHS Trust, Stanmore, United Kingdom.
  • Van Loo P; Research Department of Pathology, Cancer Institute, University College London, London, United Kingdom.
Cancer Discov ; 14(10): 1810-1822, 2024 Oct 04.
Article en En | MEDLINE | ID: mdl-38943574
ABSTRACT
Tumors frequently display high chromosomal instability and contain multiple copies of genomic regions. Here, we describe Gain Route Identification and Timing In Cancer (GRITIC), a generic method for timing genomic gains leading to complex copy number states, using single-sample bulk whole-genome sequencing data. By applying GRITIC to 6,091 tumors, we found that non-parsimonious evolution is frequent in the formation of complex copy number states in genome-doubled tumors. We measured chromosomal instability before and after genome duplication in human tumors and found that late genome doubling was followed by an increase in the rate of copy number gain. Copy number gains often accumulate as punctuated bursts, commonly after genome doubling. We infer that genome duplications typically affect the landscape of copy number losses, while only minimally impacting copy number gains. In summary, GRITIC is a novel copy number gain timing framework that permits the analysis of copy number evolution in chromosomally unstable tumors.

Significance:

Complex genomic gains are associated with whole-genome duplications, which are frequent across tumors, span a large fraction of their genomes, and are linked to poorer outcomes. GRITIC infers when these gains occur during tumor development, which will help to identify the genetic events that drive tumor evolution. See related commentary by Taylor, p. 1766.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inestabilidad Cromosómica / Variaciones en el Número de Copia de ADN / Neoplasias Límite: Humans Idioma: En Revista: Cancer Discov Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inestabilidad Cromosómica / Variaciones en el Número de Copia de ADN / Neoplasias Límite: Humans Idioma: En Revista: Cancer Discov Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido